Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report released on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

NASDAQ:CALA opened at $0.02 on Wednesday. The firm has a 50 day simple moving average of $0.02 and a 200-day simple moving average of $0.03. Calithera Biosciences has a 1-year low of $0.02 and a 1-year high of $0.50.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.